Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer

ABSTRACT:

SUBMITTER: Bajpai P 

PROVIDER: S-EPMC11238352 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature